Translational Application of Recombinant Humanized Type III Collagen in Facial Rejuvenation: A Randomized Controlled Trial

Skin aging is a common aesthetic concern that drives the demand for new therapeutic strategies. Lyophilized injectable recombinant humanized type III collagen (rhCol III) is an emerging biomaterial with promising regenerative potential; however, clinical data on its efficacy is limited. This study aimed to evaluate the safety and effectiveness of rhCol III in improving the signs of skin aging.

• Publication year

  2025

• Venue

  Journal of Cosmetic Dermatology

• Publication date

  2025-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/jocd.70529PMID 41208340PMCID 12598374
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Translational Application of Recombinant Humanized Type III Collagen in Facial Rejuvenation: A Randomized Controlled Trial

  2025cited by this paper
• Recent progress of dermal implants for aged skin rejuvenation: a review.

  2025cited by this paper
• Recombinant human collagen type III microgel: an advanced injectable dermal filler for rejuvenating aging skin

  2025cited by this paper
• Recombinant Type III Humanized Collagen Solution for Injection Improves Skin Photoaging in Chinese Population: A Case Series

  2025cited by this paper
• Efficacy and Safety of Collagen Filler for Intradermal Injection: A Randomized Prospective Controlled Multicenter Study

  2025cited by this paper
• The evidence from in vitro primary fibroblasts and a randomized, double‐blind, placebo‐controlled clinical trial of tuna collagen peptides intake on skin health

  2024cited by this paper
• An Update on the Clinical Efficacy and Safety of Collagen Injectables for Aesthetic and Regenerative Medicine Applications

  2023cited by this paper
• Skin aging from mechanisms to interventions: focusing on dermal aging

  2023cited by this paper
• Double-blind, Randomized Trial on the Effectiveness of Acetylhexapeptide-3 Cream and Palmitoyl Pentapeptide-4 Cream for Crow's Feet.

  2023cited by this paper
• Possible Mechanisms of Oxidative Stress-Induced Skin Cellular Senescence, Inflammation, and Cancer and the Therapeutic Potential of Plant Polyphenols

  2023cited by this paper
• Focus on the Contribution of Oxidative Stress in Skin Aging

  2022cited by this paper
• Modeling of the Senescence-Associated Phenotype in Human Skin Fibroblasts

  2022cited by this paper
• The Potential Use of Novel Plant-Derived Recombinant Human Collagen in Aesthetic Medicine

  2021cited by this paper
• The biological effect of recombinant humanized collagen on damaged skin induced by UV-photoaging: An in vivo study

  2021cited by this paper
• Facial Aesthetic Priorities and Concerns: A Physician and Patient Perception Global Survey

  2021cited by this paper
• Efficacy and Safety of High-Intensity, High-Frequency, Parallel Ultrasound Beams for Fine Lines and Wrinkles

  2021cited by this paper
• Connective Tissue and Fibroblast Senescence in Skin Aging.

  2021cited by this paper
• Elastic fibers during aging and disease.

  2021cited by this paper
• Update in minimally invasive periorbital rejuvenation with a focus on platelet‐rich plasma: A narrative review

  2020cited by this paper
• Role of Age-Associated Alterations of the Dermal Extracellular Matrix Microenvironment in Human Skin Aging: A Mini-Review

  2015cited by this paper
• Outcomes in Thread Lift for Facial Rejuvenation: a Study Performed with Happy Lift™ Revitalizing

  2014cited by this paper
• Oxidative Stress, Mitochondrial Dysfunction, and Aging

  2011cited by this paper
• [A photographic scale for evaluating facial pores and analysis of factors associated with pore widening in Chengdu].

  2010cited by this paper
• Bipolar fractional radiofrequency treatment induces neoelastogenesis and neocollagenesis

  2009cited by this paper

• Advances in recombinant type III collagen

  2026cites this paper
• Translational Application of Recombinant Humanized Type III Collagen in Facial Rejuvenation: A Randomized Controlled Trial

  2025cites this paper